Translator Disclaimer
1 March 2015 MILBEMYCIN OXIME (INTERCEPTOR) TREATMENT OF AMPHIPOD PARASITES (HYPERIIDAE) FROM SEVERAL HOST JELLYFISH SPECIES
Jennifer L. Boonstra, Maureen E. Koneval, James D. Clark, Mark Schick, Malissa Smith, Amy L. Stark
Author Affiliations +
Abstract

Wild-caught crystal jellyfish (Aequorea victoria) arrived at the John G. Shedd Aquarium infested with hyperiid amphipods (Hyperia medusarum), which were inadvertently introduced into a system containing several jellyfish species. Affected systems were treated with milbemycin oxime (Interceptor® tablets for dogs 51–100 lbs, Novartis Animal Health US, Inc., Greensboro, North Carolina 27408, USA), a treatment prescribed for red bug (Tegastes acroporanus) infestation in corals. Two treatments using one 25-mg aliquot of Interceptor per 10 gallons of tank water administered 6–7 days apart were completed. Overall, treatment to eradicate the parasite from the affected systems was successful. Further studies evaluating the tolerance of jellyfish to milbemycin oxime, particularly in small juvenile Eutonina indicans and Aurelia aurita, are warranted. Based on clinical observations, there were more negative effects associated with the treatment in the hydrozoans than in the scyphozoans.

American Association of Zoo Veterinarians
Jennifer L. Boonstra, Maureen E. Koneval, James D. Clark, Mark Schick, Malissa Smith, and Amy L. Stark "MILBEMYCIN OXIME (INTERCEPTOR) TREATMENT OF AMPHIPOD PARASITES (HYPERIIDAE) FROM SEVERAL HOST JELLYFISH SPECIES," Journal of Zoo and Wildlife Medicine 46(1), 158-160, (1 March 2015). https://doi.org/10.1638/2014-0087R.1
Received: 11 May 2014; Published: 1 March 2015
JOURNAL ARTICLE
3 PAGES


SHARE
ARTICLE IMPACT
RIGHTS & PERMISSIONS
Get copyright permission
Back to Top